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Abstract:
The objective of this study was to evaluate the effect of feeding Bacillus 
altitudinis spores to sows and/or offspring on growth and health 
indicators.  On day (D) 100 of gestation, 24 sows were selected and 
grouped as: control (CON), fed with a standard diet; and probiotic 
(PRO), fed the standard diet supplemented with B. altitudinis WIT588 
spores from D100 of gestation until weaning.  Offspring (n=144) from 
each of the two sow treatments were assigned to either a CON (no 
probiotic) or PRO (B. altitudinis-supplemented) treatment for 28 days 
post-weaning (pw), resulting in four treatment groups: 1) CON/CON, 
non-probiotic supplemented sow/non-probiotic supplemented piglet; 2) 
CON/PRO, non-probiotic supplemented sow/probiotic-supplemented 
piglet; 3) PRO/CON, probiotic-supplemented sow/non-probiotic 
supplemented piglet; 4) PRO/PRO, probiotic-supplemented 
sow/probiotic-supplemented piglet.  Bacillus altitudinis WIT588 was 
detected in the faeces of probiotic-supplemented sows and their piglets, 
and in the faeces and intestine of probiotic-supplemented piglets. 
 Colostrum from PRO sows had higher total solids (P=0.02), protein 
(P=0.04), and true protein (P=0.05), and lower lactose (P<0.01) than 
colostrum from CON sows.  Maternal treatment improved offspring feed 
conversion ratio at D0-14 pw (P<0.001) and increased offspring 
bodyweight at D105 and D127 pw (P=0.01), carcass weight (P=0.05) 
and kill-out percentage (P<0.01).  It also increased small intestinal 
absorptive capacity and impacted the haematological profile of sows and 
progeny.  Little impact of post-weaning treatment was observed on any 
of the parameters measured.  Overall, the lifetime growth benefits in the 
offspring of B. altitudinis-supplemented sows offer considerable 




British Journal of Nutrition
For Review Only
Page 1 of 55
Cambridge University Press




2 Maternal supplementation with Bacillus altitudinis spores improves porcine 




7 Daniel Crespo-Piazuelo1†, Gillian E. Gardiner2†*, Samir Ranjitkar1, Meike A. 
8 Bouwhuis1, Rebecca Ham2, John P. Phelan2, Alan Marsh2, and Peadar G. Lawlor1
9
10 1Pig Development Department, Animal and Grassland Research and Innovation Centre, 
11 Teagasc, Moorepark, ermoy, Co. Cork, Ireland.
12 2Eco-Innovation Research Centre, Department of Science, Waterford Institute of 
13 Technology, Waterford, Ireland.
14
15 †These authors contributed equally to this work.
16
17 *Corresponding author: Gillian Gardiner, +353 51 302626, ggardiner@wit.ie
18
19
20 Running head: Maternal and post-weaning supplementation with probiotic spores
21




Page 2 of 55
Cambridge University Press




27 The objective of this study was to evaluate the effect of feeding Bacillus altitudinis 
28 spores to sows and/or offspring on growth and health indicators.  On day (D) 100 of 
29 gestation, 24 sows were selected and grouped as: control (CON), fed with a standard 
30 diet; and probiotic (PRO), fed the standard diet supplemented with B. altitudinis 
31 WIT588 spores from D100 of gestation until weaning.  Offspring (n=144) from each of 
32 the two sow treatments were assigned to either a CON (no probiotic) or PRO (B. 
33 altitudinis-supplemented) treatment for 28 days post-weaning (pw), resulting in four 
34 treatment groups: 1) CON/CON, non-probiotic supplemented sow/non-probiotic 
35 supplemented piglet; 2) CON/PRO, non-probiotic supplemented sow/probiotic-
36 supplemented piglet; 3) PRO/CON, probiotic-supplemented sow/non-probiotic 
37 supplemented piglet; 4) PRO/PRO, probiotic-supplemented sow/probiotic-
38 supplemented piglet.  Bacillus altitudinis WIT588 was detected in the faeces of 
39 probiotic-supplemented sows and their piglets, and in the faeces and intestine of 
40 probiotic-supplemented piglets.  Colostrum from PRO sows had higher total solids 
41 (P=0.02), protein (P=0.04), and true protein (P=0.05), and lower lactose (P<0.01) than 
42 colostrum from CON sows.  Maternal treatment improved offspring feed conversion 
43 ratio at D0-14 pw (P<0.001) and increased offspring bodyweight at D105 and D127 pw 
44 (P=0.01), carcass weight (P=0.05) and kill-out percentage (P<0.01).  It also increased 
45 small intestinal absorptive capacity and impacted the haematological profile of sows 
46 and progeny.  Little impact of post-weaning treatment was observed on any of the 
47 parameters measured.  Overall, the lifetime growth benefits in the offspring of B. 
48 altitudinis-supplemented sows offer considerable economic advantages for pig 
49 producers in search of alternatives to in-feed antibiotics/zinc oxide.
50
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52 Stress at weaning can negatively impact piglet immunity and gut health, impairing 
53 growth and feed efficiency and often resulting in diarrhoea(1).  Along with the stress of 
54 weaning, passive immunity of the piglets is also reduced at this time, while active 
55 immunity is not fully developed.  This makes weaned pigs more prone to disease(2), in 
56 particular post-weaning diarrhoea which can be caused by enterotoxigenic Escherichia 
57 coli(3) or other pathogens(4).  To reduce the incidence of these pathogens and the 
58 occurrence of post-weaning diarrhoea and to prevent the weaning-associated growth 
59 check, in-feed antibiotic and/or zinc oxide treatments are frequently used(5).  However, 
60 following the ban of in-feed antibiotic growth promoters in the European Union (EU) in 
61 2006, a ban on the preventive use of antibiotics in groups of animals and via medicated 
62 feed will enter into force in the EU in 2022.  In the same year, the use of 
63 pharmacological levels of zinc oxide will also be banned.  As a result, alternative 
64 treatments, such as probiotics will be of increased importance in the future.  Probiotics 
65 not only control pathogens, but they can also improve pig growth and feed 
66 efficiency(5,6).
67 Bacteria from Bacillus spp. are commonly used as probiotics in pig production(7–9).  
68 Species from this genus form spores, which increases their resistance to hostile 
69 conditions such as those encountered in the gastrointestinal tract and during feed 
70 manufacture(10,11).  In addition, the vegetative cells of Bacillus spp. produce extracellular 
71 enzymes, which can increase nutrient availability in the diet and improve 
72 digestibility(12), and Bacillus are well-known for the production of antimicrobials(13–15).  
73 On this basis, many studies which administered spores of Bacillus spp. to weaned pigs 
74 found improved growth performance and feed conversion(16–18), while the incidence of 
75 post-weaning diarrhoea was also reduced in some cases(19).  Nevertheless, commencing 
76 the administration of Bacillus spores to pigs post-weaning may not be the most effective 
77 strategy.  Firstly, it may be too late, as evidence suggests that early-life gut microbiota 
78 interventions are more effective(20–25).  Secondly, the spores may not germinate in the 
79 gastrointestinal tract(26); and lastly, which may/may not be related to lack of 
80 germination, Bacillus administered as spores do not usually persist for more than one 
81 week after ceasing administration(12). 
82 A cheaper and potentially more effective alternative to probiotic supplementation of 
83 post-weaning diets is the inclusion of Bacillus spores in the diet of gestating and/or 
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84 lactating sows.  Vertical transmission of the probiotic from sows to their offspring then 
85 occurs between birth and weaning(27,28), although this is sometimes limited(29).  Maternal 
86 administration can also benefit the sow, minimizing weight loss during lactation and 
87 improving reproductive performance and milk quality(18,20,30,31).  These maternal 
88 benefits sometimes increase the number of piglets weaned per sow(30), although some 
89 studies did not find any significant effects on sow productivity(22,24,27,28).  Probiotic 
90 administration to sows also leads to improved weight gain and feed efficiency in the 
91 offspring post-weaning(18,20,22,28).  However, the mechanisms by which maternal 
92 probiotic supplementation benefits offspring growth are not fully understood.  Probiotic 
93 administration stimulates the immune system of sows, which confers passive immunity 
94 to offspring through colostrum and milk(32).  Stimulation of the immune system of the 
95 piglets may even start before the piglets are born, as piglets become immunocompetent 
96 in utero and their active immunity depends on maternal antibody levels(33).  
97 Furthermore, the faecal bacterial community of the sows, including any administered 
98 probiotic and/or probiotic-modulated taxa, can be transferred to their litter through the 
99 intake of maternal faeces(28).
100 However, most studies that administer probiotics to gestating/lactating sows do not 
101 follow the growth of offspring beyond the weaner stage, as they are usually focused on 
102 the incidence of post-weaning diarrhoea(7,18,20,24,27–29,31).  The aim of the present study 
103 was therefore to evaluate the efficacy of a novel Bacillus altitudinis probiotic delivered 
104 as spores to sows and/or their offspring on sow health, reproductive performance and 
105 colostrum quality, as well as on lifetime growth and health and carcass characteristics of 
106 the offspring.  
107
108 Materials and Methods
109 Ethical approval 
110 Ethical approval for this study was granted by the Teagasc Animal Ethics Committee 
111 (approval no. TAEC148/2017) and the project was authorised by the Health Products 
112 Regulatory Authority (project authorisation no. AE19132/P066).  The experiment was 
113 conducted in accordance with Irish legislation (SI no. 543/2012) and the EU Directive 
114 2010/63/EU for animal experimentation.
115
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116 Experimental design and diets
117 A total of 24 sows (Large White × Landrace; Hermitage Genetics, Sion Road, Co. 
118 Kilkenny, Ireland) were selected on day 100 (D) 100 of gestation and blocked by parity, 
119 body weight (BW) and back fat (BF) depth, following which they were individually 
120 housed and randomly assigned to one of two experimental treatment groups as follows: 
121 1) control (CON, n=12), fed with a standard gestation diet from D100 of gestation to 
122 farrowing, followed by a standard lactation diet for 26 days until litters were weaned; 
123 and 2) probiotic (PRO, n=12), fed the standard gestation/lactation diet supplemented 
124 with B. altitudinis WIT588 spores (~4×109 spores daily from D100 of gestation to 
125 farrowing and ~1.2×1010 spores daily during lactation for 26 days until weaning of 
126 litters, administered as outlined below).  Cross-fostering of piglets was performed 
127 between 24 and 48 h post-partum to equalize litter size (14 piglets/litter) if necessary, 
128 but only within the same treatment group.  
129 At weaning (at D26 ± 1.5 of age), a total of 144 piglets from these sows (n=72/sow 
130 treatment) were selected across all litters, blocked by sow treatment, sex, BW and litter 
131 origin and randomly assigned to dietary treatments.  Offspring from each of the two sow 
132 treatments were assigned as same gender pairs of pigs to either a CON (no probiotic) or 
133 PRO (probiotic-supplemented) treatment for 28 days post-weaning (pw), resulting in 
134 four treatment groups (n=36 piglets/treatment) as follows: 1) piglets weaned from CON 
135 sows, fed a CON diet (CON/CON); 2) piglets weaned from CON sows, fed a probiotic-
136 supplemented diet (CON/PRO); 3) piglets weaned from PRO sows, fed a CON diet 
137 (PRO/CON); and 4) piglets weaned from PRO sows, fed a probiotic-supplemented diet 
138 (PRO/PRO).  Probiotic supplementation consisted of ~1×109 CFU of B. altitudinis 
139 WIT588 spores administered daily, as outlined below.  Probiotic supplementation 
140 ceased at D28 pw, but pigs were monitored until the end of the finisher period (~D127 
141 pw).  A starter/link diet was fed for the first 28 days pw, followed by a weaner diet until 
142 D55 pw, and thereafter a finisher diet was fed until slaughter at D127 pw.
143 The ingredient composition and nutrient content of all sow and offspring diets are 
144 shown in Table 1.  The diets were manufactured in the Teagasc feed mill (Moorepark, 
145 Fermoy, Co. Cork) and were formulated to meet or exceed National Research Council 
146 recommendations (NRC, 2012)(34) for pigs at the relevant stage of the production cycle.  
147 All starter/link diets were formulated with 10.74 MJ/kg net energy and 14.0 g/kg 
148 standardised ileal digestible lysine (SID Lys) using the same ingredients.  Similarly, the 
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149 weaner diet was formulated with 10.55 MJ/kg net energy and 11.49 g/kg SID Lys.  The 
150 finisher diet was formulated with 9.80 MJ/kg net energy and 9.97 g/kg SID Lys.  All 
151 diets were fed in 3 mm pellet form.  Sows were fed 2.7 kg/day of feed up to the day of 
152 farrowing and thereafter were provided with ad libitum access to feed from a trough 
153 using a computerised feed delivery system (DryExact Pro, Big Dutchman, Vechta, 
154 Germany).  Water was available on an ad libitum basis to sows during gestation and 
155 lactation from a single-bite drinker in the feed trough and to suckling piglets from a 
156 bowl in the farrowing pen.  Suckling piglets were offered creep feed in pelleted form 
157 from D12 of age to weaning.  At all stages post-weaning, pigs were provided with ad 
158 libitum access to feed from a 30 cm wide stainless-steel feeder (O’Donovan 
159 Engineering, Coachford, Co. Cork, Ireland) and to water from one nipple-in-bowl 
160 drinker (BALP, Charleville-Mezieres, Cedex, France).  Representative samples were 
161 taken from all diets and analysed for dry matter, ash, crude protein, total oil, crude fibre, 
162 and neutral detergent fibre by Sciantec Analytical Services Limited, Cawood, UK.
163
164 Preparation and administration of probiotic spores
165 Bacillus altitudinis WIT588 is a rifampicin resistant variant of a seaweed-derived 
166 isolate (WIT572; NCIMB 43558) characterized, both in vitro and in vivo as a probiotic 
167 for pigs, used to facilitate enumeration in the porcine gastrointestinal tract(26,35,36).  The 
168 strain was first referred to as B. pumilus on the basis of sequencing of the gyrB and pyrE 
169 genes(26), but has since been identified as B. altitudinis on the basis of whole genome 
170 sequencing (unpublished data).  The B. altitudinis WIT588 spore suspension used in the 
171 current feeding trial was prepared according to the nutrient exhaustion method 
172 described by Prieto et al. (2014)(36) and the spores were suspended in sterile water.  The 
173 concentration was then determined using a haemocytometer and adjusted to ~109 
174 spores/ml.  Aliquots of this spore suspension were stored at -20°C until use.  Probiotic 
175 spores were administered once daily in the morning to the respective treatment groups.  
176 The doses used for sows and weaned pigs, as outlined above, were calculated based on 
177 data from previous experiments and doses used for comparable commercially available 
178 probiotics.  The amount of spore suspension required each day was thawed over night at 
179 4oC.  On the morning of administration, spore suspensions were diluted in distilled 
180 water to the required dose and top-dressed onto the feed in a final volume of 4 ml for 
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181 gestating sows and weaned pigs and 12 ml for lactating sows.  The same volume of 
182 sterile water was top-dressed onto the feed of CON pigs not administered probiotic.
183
184 Animal housing and management
185 PRO sows were housed separately from CON sows, with two farrowing rooms for PRO 
186 sows, each with 7 pens per room, and one room for CON sows with 14 pens per room.  
187 Farrowing pens (2.5 m × 1.8 m) had a farrowing crate on a partially slatted floor with a 
188 heated floor pad for piglets.  The temperature of the farrowing rooms was maintained at 
189 ~24°C at farrowing and gradually reduced to 21°C by D7 of lactation.  Each room was 
190 illuminated by daylight and artificial light.  The temperature inside the building was 
191 automatically controlled.  Ventilation was via punched ceiling ventilation with air 
192 exhausted via a variable speed fan linked to a thermostat and controlled automatically 
193 via a controller (135-L2 Pro climate computer; Big Dutchman, Vechta, Germany) 
194 outside each room.
195 At weaning, piglets were housed in same gender pairs in 72 pens (n=2 pigs/pen) across 
196 4 rooms.  Each room contained 24 pens (1.2 m × 0.9 m), with treatments distributed 
197 equally across rooms.  Pens were fully slatted with plastic flooring (Faroex, Manitoba, 
198 Canada).  Empty pens were left between treatments to minimise probiotic cross-
199 contamination and strict hygiene procedures were followed.  Pigs were penned as pairs 
200 for the first 7 days post-weaning.  A total of 40 pigs (n=10/treatment; one pig from each 
201 of 10 pen pair replicates per treatment) were sacrificed by captive bolt stunning 
202 followed by exsanguination on D8 pw to facilitate sampling of digesta and intestinal 
203 tissue.  To coincide with this, one pig from each of the remaining pairs of pigs was 
204 removed from the trial at this time also and the remaining piglets (n=72) were 
205 individually penned until slaughter at D127 pw.  The temperature of the weaner rooms 
206 was maintained at 28°C for the first 7 days pw, gradually reduced to 22°C by D28 pw 
207 and maintained at 22°C until D56 pw.  Temperature and ventilation were controlled by 
208 a hot air heating system and an exhaust fan drawing air from under slat level connected 
209 to a controller (Stienen PCS 8400; Stienen BV, Nederweert, the Netherlands).  At D56 
210 pw, pigs were moved to one of 4 finisher rooms, each with 18 pens/room, where they 
211 were individually penned in fully slatted pens (1.81 m × 1.18 m) until the end of the 
212 experimental period (D127 pw).  Pigs were kept in the same order as in the weaner 
213 rooms but without the empty pen between treatments.  Finisher rooms were ventilated 
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214 with fans and air inlets controlled by a Stienen PCS 8200 controller (Stienen BV).  Air 
215 temperature was maintained at 20 to 22°C.  Sows and piglets were observed closely at 
216 least twice daily.  Any pig showing signs of ill health was treated as appropriate and this 
217 was recorded.  All veterinary treatments were recorded, including identity of pig, 
218 symptom, medication used and dosage.
219
220 Data recording and sampling 
221 During sampling and weighing of sows and offspring, strict hygienic measures were 
222 taken to prevent cross-contamination between treatments.  CON pigs not receiving 
223 probiotic were handled first, followed by PRO treatment groups.  Gloves were changed 
224 between pigs, and fresh disposable overalls were worn by all personnel prior to 
225 commencing sampling of each treatment group.  All equipment, such as weighing scales 
226 and the cradle used for collection of blood samples was disinfected thoroughly with 1% 
227 Virkon® after use to prevent cross contamination at subsequent weighings/samplings.  
228 In both CON and PRO farrowing rooms and beside both PRO and CON pens within the 
229 weaner rooms, settle plates containing agar medium selective for the probiotic strain 
230 (see below) were exposed for 30 min at faecal sampling time points, and incubated with 
231 the faecal sampling plates as outlined below in order to check for the presence of the 
232 probiotic strain in the air.
233
234 Sow body weight and back fat thickness 
235 Feed intake of sows was recorded daily between D100 of gestation and D28 of 
236 lactation.  Body weight and BF were recorded at the start of the experiment (D100 of 
237 gestation), on the expected farrowing date (D114 of gestation), and again at weaning of 
238 litters (~D26 of lactation).  Sow BW was recorded using an electronic sow scales 
239 (EziWeigh 7i, O’Donovan Engineering, Co. Cork, Ireland).  Sow BF was measured 
240 using a digital BF indicator (Renco LEAN-MEATER, Renco Corporation, Golden 
241 Valley, Minneapolis, USA) by placing the probe of the digital indicator on the back of 
242 the sow at the level of the second last rib, 6.5 cm from the side of the backbone.  A 
243 reading was taken from the right and left side of the sow’s back and the average of both 
244 readings was recorded.
245
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246 Colostrum and milk sampling
247 Colostrum samples (n=12 sows/treatment) were collected by manual milking of the first 
248 four teats immediately distal to the sow’s head on one side of the udder within 12 h of 
249 farrowing.  On D14 of lactation, milk samples were collected from sows (n=12 
250 sows/treatment) in the same way but this time following administration of a 1 ml (10 
251 IU) intramuscular injection of oxytocin (Eurovet 247 Animal Health, Bladel, 
252 Netherlands) to induce milk let-down.  All samples were stored at -20°C until analysis.
253
254 Litter data at birth and pre-weaning piglet growth performance 
255 Reproductive parameters were recorded per litter i.e. number of piglets (total born, born 
256 alive, stillborn).  The weight and sex of each piglet was recorded at birth, and each 
257 piglet was tagged for identification purposes.  Thereafter, piglets were individually 
258 weighed at birth (D0), D14 and D26 post-partum and these data was used to determine 
259 pre-weaning piglet average daily gain (ADG).  Piglet mortality between birth and 
260 weaning was also recorded.
261
262 Post-weaning growth performance, faecal scoring and carcass measurements
263 Growth performance of piglets was measured by weighing pigs individually and 
264 monitoring individual feed intake in order to calculate ADG, average daily feed intake 
265 (ADFI), and feed conversion ratio (FCR).  Feed disappearance was recorded weekly and 
266 pigs were individually weighed at weaning (D0 pw), D14 pw, the changeover to weaner 
267 feed (D28 pw), changeover to finisher feed (D56 pw), D105 pw and immediately before 
268 slaughter (D127 pw).  Pigs were fasted for 12 h prior to pre-slaughter weighing.
269 The incidence of post-weaning diarrhoea was assessed by daily faecal consistency 
270 scoring between weaning and D28 pw.  The scoring system used was as follows: 0 for 
271 dry pelleted faeces; 1 for soft faeces with shape; 2 for very soft or viscous liquid faeces 
272 (mild diarrhoea); and 3 for severe diarrhoea with or without blood.
273 Pigs were slaughtered at ~123.5 ± 1.38 kg SEM live-weight by CO2 stunning followed 
274 by exsanguination.  Carcass weight was estimated by multiplying the weight of the hot 
275 eviscerated carcass 45 min after slaughter by 0.98.  Kill out percentage was calculated 
276 as carcass weight/live-weight at slaughter.  Back fat thickness and muscle depth 
277 measured at 6 cm from the edge of the split back at the level of the 3rd and 4th last rib 
278 were determined using a Hennessy Grading Probe (Hennessy and Chong, Auckland, 
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279 New Zealand).  Lean meat content was estimated according to the following formula: 
280 Estimated lean meat content (%) = 60.3 – 0.847x + 0.147y where x = fat depth (mm); y 
281 = muscle depth (mm)(37).
282
283 Faecal sampling 
284 Faecal samples were collected from sows (n=24) directly from the rectum using gentle 
285 digital stimulation on D100 and D115 of gestation, ~D13 of lactation and at weaning of 
286 litters (~D26 of lactation).  Pre-weaning, rectal swabs were taken from offspring on 
287 ~D13 of lactation (n=12 pig replicates per treatment) and faecal samples were obtained 
288 by digital rectal stimulation at weaning (n=10 pig replicates per treatment), D27 pw and 
289 D56 pw (n=10 pig replicates per treatment).  Faeces were collected into sterile 
290 containers and, together with swabs, were put on ice and stored at 4°C until analysis for 
291 the administered probiotic strain (within 12 h), as outlined below.
292
293 Blood sampling
294 Blood samples were taken from sows (n=24) by anterior vena cava/jugular 
295 venepuncture on D100 and D114 of gestation and at weaning of litters (~D26 of 
296 lactation).  Piglets (n=10 pig replicates per treatment) were blood sampled by anterior 
297 vena cava/jugular venepuncture on D0 pw, D28 pw and D57 pw.  Blood samples were 
298 also collected from piglets sacrificed at D8 pw (n=10 pig replicates per treatment) 
299 following exsanguination.  In all cases, ~1-2 ml of whole blood was collected in a 
300 Vacutainer® tube containing EDTA (Becton-Dickson Ltd, Plymouth, UK) (except at 
301 sacrifice when the volume was ~9 ml) and immediately inverted a number of times to 
302 prevent clotting.  Samples were kept at room temperature and haematological analysis 
303 performed within 6 h, as outlined below.
304
305 Intestinal sampling
306 After euthanasia of piglets on D8 pw (n=10 pig replicates per treatment) the entire 
307 intestinal tract was immediately removed.  Digesta samples from the ileum (15 cm 
308 proximal to the ileo-caecal junction), cecum (terminal tip) and rectum were collected 
309 aseptically into sterile containers, put on ice and stored at 4°C until analysis for the 
310 administered probiotic strain (within 12 h), as outlined below.  Samples (~2 cm) of 
311 tissue were excised from the duodenum (15 cm distal to the pyloric junction), jejunum 
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312 (1.5 m distal to the pyloric junction) and the ileum (15 cm proximal to the ileo-caecal 
313 junction).  Tissue samples were rinsed in phosphate buffered saline (PBS) immediately 
314 post-harvest and placed in No-Tox, an alcohol/aldehyde fixative (Scientific Device Lab, 
315 Des Plaines, IL, USA) on a shaker for 48 h prior to histological analysis, as outlined 
316 below.
317
318 Compositional analysis of sow colostrum and milk
319 Colostrum and milk samples were defrosted at room temperature.  When fully thawed, 
320 samples were mixed by inverting several times to disrupt settled solids and mixed well.  
321 The volume of each sample was recorded prior to decanting into 50 ml tubes on ice.  
322 Sterile water was added to bring the volume up to 40 ml.  Tubes were mixed thoroughly 
323 and kept on ice.  Each sample was analysed in duplicate for total solids, lactose, fat, 
324 protein, true protein and casein B content by near-infrared absorption using a Bentley 
325 Dairyspec FT (Bentley Instruments, Inc., Chaska, MN, USA).  Data were recorded as % 
326 (g/100g), taking the dilution factor into account.
327
328 Immunoglobulin A and Immunoglobulin G quantification in colostrum
329 Immunoglobulin A (IgA) and Immunoglobulin G (IgG) concentrations in colostrum 
330 were determined using ELISA kits (Pig IgA and IgG ELISA Kits, Bethyl Laboratories 
331 Inc., Texas, USA).  First, 200 μl of colostrum was diluted 1:2 with PBS (1X, pH 7.4) 
332 and centrifuged at 10,000 rpm for 20 min at 4°C.  The fat was then removed and the 
333 supernatant was collected and diluted 1:100,000 and 1:500,000 with 1X Dilution Buffer 
334 B (Bethyl Laboratories Inc.) for IgA and IgG analyses, respectively.  The rest of the 
335 analysis was performed according to the manufacturer’s protocol.  All colostrum 
336 samples were analysed in duplicate.  Absorbance was measured at 450 nm using a plate 
337 reader (ELx808 Absorbance Microplate Reader, BioTek, Vermont, USA).  The IgA and 
338 IgG concentrations in the colostrum were obtained by reading absorbance values from 
339 standard curves prepared using standard solutions containing 1,000.0, 333.3, 111.1, 
340 37.0, 12.3, 4.1 and 1.4 ng/ml of IgA and 500.0, 250.0, 125.0, 62.5, 31.3, 15.6 and 7.8 
341 ng/ml of IgG.
342
343 Small intestinal histology
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344 Duodenal, jejunal, and ileal tissue samples were removed from the No-Tox fixative and 
345 dehydrated through a graded alcohol series, cleared with xylene and embedded in 
346 paraffin wax.  Tissue samples were sliced into 5 micrometre sections using a microtome 
347 (Leica RM2135, Wetzlar, Germany), mounted on microscope slides and stained with 
348 hematoxylin and eosin for determination of gross morphological parameters of 
349 intestinal structure (villus height and width and crypt depth and width).  For each pig, 
350 10 villi and 10 crypts were measured on five fields of view, where villi were attached to 
351 the lumen, and the means were utilised for statistical analysis.  The goblet cell number 
352 was determined by periodic acid-Schiff staining.  Positively stained periodic acid-Schiff 
353 cells were enumerated on 10 villi/sample, and the means were utilised for statistical 
354 analysis.
355
356 Microbiological analysis of faecal and digesta samples
357 Faecal and digesta samples and rectal swabs were homogenized and subsequently 
358 diluted in maximum recovery diluent (MRD; Merck, Darmstadt, Germany) as described 
359 by Gardiner et al. (2004)(38).  Appropriate dilutions were spread-plated in duplicate on 
360 brain heart infusion agar containing 3.5% NaCl, 200 μg/ml rifampicin (Sigma-Aldrich, 
361 Arklow, Co. Wicklow, Ireland), and 50 U/ml nystatin (Sigma-Aldrich) in order to 
362 enumerate the administered probiotic strain.  Plates were incubated aerobically for 2 
363 days at 37°C, the colonies were counted and the counts averaged and presented as log10 
364 CFU/g of the original sample or log10 CFU/swab.
365
366 Haematological analysis of blood samples
367 Haematological analysis was performed on whole blood using an Abbot Cell-Dyn 3700 
368 analyser (GMI-Inc, Minnesota, USA).  The following parameters were measured; white 
369 blood cell (WBC) number, lymphocyte number and percentage, monocyte number and 
370 percentage, granulocyte number and percentage, eosinophil number and percentage, 
371 basophil number and percentage, red blood cell (RBC) number, haemoglobin, mean 
372 corpuscular volume, mean corpuscular haemoglobin, platelets and packed cell volume.
373
374 Statistical analysis
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375 Power calculations were performed to determine the minimum number of observations 
376 required to detect effect sizes, using a statistical power of 80%, an α level at 5% and 
377 standard deviation of variables of interest from 7 previously published studies.  The 
378 power calculation indicated that 12 sows per treatment were required to see a difference 
379 of 2.5 mm in BF depth, 10 piglets were required to see a 2 log10 CFU/g difference in 
380 selected microbial counts between treatments and that 18 piglets were required to see a 
381 1.5 log10 CFU/g difference in microbial counts between treatments.
382 The experiment was a 2 × 2 factorial arrangement, with the factors being maternal 
383 treatment (control or probiotic supplementation) and post-weaning treatment (control or 
384 probiotic supplementation).  All data were analysed using the MIXED procedure in 
385 SAS® 9.4 (SAS Institute, Inc., Cary, NC, US), unless otherwise stated.  The model 
386 included maternal treatment and post-weaning treatment as fixed effects and their 
387 interaction.  Where required, data were analysed as a repeated measure with sampling 
388 day as the repeated variable and the appropriate covariance structure, as indicated by the 
389 model fit statistics, was fitted to the data.  Simple main effects were obtained using the 
390 ‘slice’ option in SAS.
391 The sow/litter was the experimental unit for sow performance, sow haematology, sow 
392 probiotic count data, colostrum and milk composition and colostrum IgA and IgG.  The 
393 individual pig was the experimental unit for analysis of pre- and post-weaning pig 
394 growth performance, carcass characteristics, haematology, small intestinal morphology 
395 and probiotic count data.  The normality of scaled residuals was investigated using the 
396 Shapiro-Wilk and Kolmogorov-Smirnov tests within the UNIVARIATE procedure of 
397 SAS.  Differences in least square means were investigated using the t-test after Tukey 
398 adjustment for multiple comparisons.  Degrees of freedom were estimated using 
399 Satterthwaite adjustment.
400 For sow performance, litter size, and pre-weaning mortality data, block was included as 
401 a random effect.  The initial value (D100 of gestation) was included as a covariate in the 
402 analysis when significant in the model.  Pre-weaning performance was analysed as 
403 repeated measures, including sex (male, female) as a fixed effect and block as a random 
404 effect.  Birth weight was included as a covariate when significant in the model.  Post-
405 weaning performance was analysed as repeated measures, including sex (male, female) 
406 as fixed effect and weaning weight as a covariate, when significant in the model.  For 
407 carcass characteristics, sex (male, female) was included as a fixed effect and BW at 
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408 weaning was included as a covariate when significant in the model.  Counts of B. 
409 altitudinis WIT588 were analysed as repeated measurements.  For the faecal counts of 
410 B. altitudinis WIT588 in the sows, block was included as a random effect.  For the 
411 faecal counts of B. altitudinis WIT588 in the post-weaned piglets, the count at weaning 
412 was included as a covariate in the analysis, when significant.  Haematological 
413 parameters were analysed including the initial value (D100 of gestation for sows or D0 
414 pw for the offspring) as a covariate in the analysis when significant in the model.  In 
415 addition, block was included as a random effect for the haematological values of sows.  
416 The haematological parameters that were not normally distributed were further analysed 
417 to find the best fitting distribution using the GLIMMIX procedure in SAS, using a 
418 gamma distribution.  or these variables, the ilink function was used to back-transform 
419 the data to the original scale.  The small intestinal morphology data were analysed using 
420 sex (male, female) as a fixed effect.
421 The results are presented in the text and tables as the least square means together with 
422 the pooled standard errors of the mean.  Differences between treatments were 
423 considered significant for P≤0.05, while 0.05<P≤0.10 was considered as a tendency.
424
425 Results
426 Sow reproductive performance and tissue mobilisation 
427 The effect of supplementing sow diets with Bacillus altitudinis WIT588 spores from 
428 D100 of gestation to weaning (D26 of lactation) on sow weight, BF depth, feed intake 
429 and reproductive performance is presented in Supplementary Table S1.  There was no 
430 treatment × day interaction for any of the variables of interest.  Sows from the CON 
431 group were heavier than those in the PRO group at weaning (257.0 vs 248.7 ± 2.71 kg; 
432 P=0.03).  However, gestation length (114.8 vs 114.6 ± 0.33 days), total born per litter 
433 (14.62 vs 15.49 ± 1.253), live born per litter (13.50 vs 13.97 ± 1.170), percentage of 
434 piglets live born per litter (93.3 vs 90.8 ± 3.25 %), stillbirths per litter (1.15 vs 1.51 ± 
435 0.592) and the numbers of piglets suckling per litter at 48h post-partum (14.3 vs 14.2 ± 
436 0.40) were not affected by sow treatment (P>0.1).  Although not significant, there was a 
437 numerical reduction in pre-weaning mortality (15.6 vs 10.1 ± 2.82 %; P=0.18) when the 
438 probiotic was fed and because of this a numerical increase in the number of piglets 
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439 weaned per litter (11.8 vs 12.6 ± 0.55; P=0.29) in response to probiotic supplementation 
440 of sows.
441
442 Recovery of Bacillus altitudinis WIT588 from the faeces of sows and their litters 
443 during lactation
444 Faecal counts of the administered probiotic (B. altitudinis WIT588) from the faeces of 
445 sows during gestation and lactation and from their offspring during lactation are shown 
446 in Table 2.  Prior to commencing probiotic treatment (D100 of gestation), B. altitudinis 
447 WIT588 was not detected in the faeces of either CON or PRO sows.  There was a 
448 treatment × day interaction for faecal counts of B. altitudinis WIT588 in sows.  Counts 
449 of B. altitudinis WIT588 increased over time in PRO sows from D100 of gestation until 
450 D13 of lactation, declining slightly on D26 of lactation (P<0.001).  Faecal counts of B. 
451 altitudinis WIT588 were higher in PRO than in CON sows at all time points during 
452 probiotic administration (D115 of gestation, and D13 and D26 of lactation; P<0.001), as 
453 the administered probiotic was essentially undetectable in CON sows.  Although not 
454 administered the probiotic themselves, most of the offspring from PRO sows shed B. 
455 altitudinis WIT588 by D13 of age.  There was a treatment × day interaction for faecal 
456 counts of B. altitudinis WIT588 in the offspring of PRO sows, with probiotic counts 
457 increasing over time (P<0.001).  However, counts are not comparable, as the D13 count 
458 is presented as CFU/swab and the D26 count as CFU/g faeces.  Similar effects were 
459 observed in the offspring as in the sows, in that piglets born to PRO sows had higher 
460 faecal counts of B. altitudinis WIT588 at D13 and D26 of age than piglets born to CON 
461 sows (P<0.001), again due to lack of probiotic detection in the offspring from CON 
462 sows.
463
464 Haematological parameters of sows during gestation and lactation
465 The full results for all haematological parameters measured in sows are presented in 
466 Supplementary Table S2.  Only results for haematological parameters where there 
467 were significant treatment differences are reported in Table 3.  There was a tendency 
468 for a treatment × day interaction for mean corpuscular haemoglobin concentration 
469 (P=0.09), which decreased on D114 of gestation in CON sows, increasing again at 
470 weaning (D26 of lactation).  The only treatment difference found for blood cell counts 
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471 was for basophils.  Overall, PRO sows had a higher basophil count than CON sows 
472 (P<0.01).  This was also found on D114 of gestation (P=0.04) and a tendency for this 
473 effect was found on the day of weaning (D26; P=0.07).  Similar results were found for 
474 the overall percentage of basophils, where PRO sows had higher levels than CON sows 
475 (P=0.001).  This was also found on D114 of gestation (P=0.05) and on the day of 
476 weaning (D26; P<0.01).  Regarding the other parameters measured, treatment 
477 differences were also observed for mean corpuscular volume and mean corpuscular 
478 haemoglobin.  Overall, CON sows had higher mean corpuscular volume than PRO sows 
479 (P<0.001) and this was also found on D114 of gestation (P=0.001) and on the day of 
480 weaning (D26; P<0.01).  Overall, CON sows had greater mean corpuscular 
481 haemoglobin levels than PRO sows (P =0.001) and this was also found on D114 of 
482 gestation (P=0.01) and at weaning (D26; P=0.001).  In addition, the mean corpuscular 
483 haemoglobin concentration was higher for PRO sows than for CON sows on D114 of 
484 gestation (P=0.04).
485
486 Colostrum and milk composition 
487 The effect of supplementing sow diets with B. altitudinis WIT588 spores from D100 of 
488 gestation to weaning of litters (D26 of lactation) on the composition of sow colostrum 
489 and milk is shown in Table 4.  Colostrum composition was impacted by maternal 
490 treatment for all of the parameters measured, with the exception of fat percentage 
491 (P=0.75) and IgA and IgG concentrations (P=0.46 and P=0.34, respectively).  The 
492 colostrum from PRO sows had a higher percentage of total solids (P=0.02), protein 
493 (P=0.04), true protein (P=0.05) and casein B (P=0.05), and had less lactose (P=0.01) 
494 than the colostrum from CON sows.  However, milk composition was not affected by 
495 sow treatment (Table 4).
496
497 Pre-weaning and post-weaning pig growth performance
498 Pig weights and average daily gains while suckling the sow were not affected by 
499 treatment (Supplementary Table S3; P>0.05).  Birth weight averaged 1.47 ± 0.029 kg 
500 and weaning weight averaged 7.27 ± 0.168 kg for piglets from both treatments.
501 The effects of B. altitudinis WIT588 spore supplementation to sow and piglet diets on 
502 post-weaning growth and carcass characteristics are shown in Table 5.  No maternal 
Page 17 of 55
Cambridge University Press
British Journal of Nutrition
For Review Only
17
503 treatment × post-weaning treatment × day interaction was found.  A maternal treatment 
504 × post-weaning treatment interaction was found for BW on D127 pw (P=0.05) with a 
505 tendency for the same on D105 pw (P=0.07) and overall (P=0.09).  On D105 pw, 
506 PRO/PRO pigs tended to be heavier than CON/PRO pigs and on D127 pw, PRO/PRO 
507 pigs were heavier than pigs born to CON sows.  At D105 pw BW was 91.7 and 95.2 ± 
508 0.98 kg (P=0.01), while at D127 pw it was 121.0 and 124.5 kg ± 0.97 (P=0.01) for pigs 
509 born to CON and PRO sows, respectively.  Overall, pigs born to PRO sows were 
510 heavier than pigs born to CON sows (P=0.01).  Average daily gain from D0 to D127 pw 
511 was 890 and 922 ± 10.9 g/day (P=0.04) for pigs born to CON and PRO sows, 
512 respectively.  Overall, pigs born to PRO sows had higher ADG than pigs born to CON 
513 sows (P=0.04).  A maternal treatment × post-weaning treatment interaction was found 
514 for FCR from D0 to D14 pw (P<0.001), where PRO/CON pigs had better FCR than 
515 CON/PRO pigs.  During this period (D0-D14 pw), pigs born to PRO sows had better 
516 FCR than those born to CON sows (1.28 vs 1.45 ± 0.030 g/g; P<0.001).  A maternal 
517 treatment effect for FCR was also observed for the overall period (P=0.02).  A post-
518 weaning treatment effect was observed from D0 to D14 pw, where CON pigs had better 
519 FCR than PRO pigs (1.30 vs 1.43 ± 0.030 g/g; P<0.01).  A tendency for a post-weaning 
520 treatment effect was also observed from D57 to D105 pw and during the entire post-
521 weaning period (D0-127 pw), but this time with PRO pigs having a better FCR than 
522 CON pigs [2.21 vs 2.13 ± 0.032 g/g (P=0.06) and 2.07 vs 2.04 ± 0.014 g/g (P=0.07), 
523 respectively].
524 There was no maternal treatment × post-weaning treatment interaction for carcass 
525 weight or carcass quality parameters (P>0.05).  Carcass weight and kill out percentage 
526 were 90.9 and 94.4 ± 1.22 kg (P=0.05) and 75.0 and 75.9 ± 0.187 % (P<0.01) for pigs 
527 born to CON and PRO sows, respectively.  There was no effect of post-weaning 
528 treatment on carcass weight or carcass quality parameters (P>0.05).
529
530 Recovery of Bacillus altitudinis WIT588 from the faeces and intestinal digesta of 
531 pigs post-weaning
532 Counts of the administered B. altitudinis probiotic in the faeces and ileal, caecal and 
533 rectal digesta of the offspring post-weaning are shown in Table 6.  No maternal 
534 treatment × post-weaning treatment × day interaction was found.  A maternal treatment 
535 × post-weaning treatment interaction was found at D27 pw (P<0.001) and a tendency 
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536 for this effect was also found at weaning (P=0.08).  At weaning B. altitudinis WIT588 
537 counts tended to be higher in the faeces of PRO/CON than PRO/PRO piglets.  A 
538 maternal treatment effect was observed at weaning, where piglets born to PRO sows 
539 had higher B. altitudinis WIT588 counts than those born to CON sows (4.70 vs 3.00 ± 
540 0.088 log10 CFU/g faeces; P<0.001), due to lack of detection in the latter.  At D8 pw, 
541 post-weaning treatment affected counts in the intestinal digesta.  Bacillus altitudinis 
542 WIT588 counts were higher in the ileal, caecal and rectal digesta of PRO compared to 
543 CON piglets (P<0.001), as the administered strain was undetectable in the latter.  
544 Bacillus altitudinis WIT588 counts were also higher in the faeces of PRO versus CON 
545 piglets on D27 pw (5.93 vs 3.00 ± 0.021 log10 CFU/g faeces; P<0.001) and there was a 
546 tendency for this effect at weaning (3.96 vs 3.74 ± 0.088 log10 CFU/g faeces; P=0.08).
547
548 Faecal scoring of pigs post-weaning
549 Statistical analysis of the probiotic effect on post-weaning diarrhoea prevalence could 
550 not be conducted, as the occurrence of faecal consistency scores higher than 0 was rare.  
551 Out of 504 faecal consistency scores given to each one of the four treatments up to D28 
552 pw, a score of 1 (soft faeces with shape) was given 45 times to the CON/CON treatment 
553 group, 28 times to the CON/PRO treatment group, 38 times to the PRO/CON treatment 
554 group and 27 times to the PRO/PRO treatment group.  No scores higher than 1 were 
555 given at any time to any animal.
556
557 Haematological parameters of pigs post-weaning
558 The effects of Bacillus altitudinis WIT588 supplementation to sow and piglet diets on 
559 the haematological parameters of pigs post-weaning are shown in Table 7.  No maternal 
560 treatment × post-weaning treatment × day interactions were found for any of the 
561 parameters measured, except for mean corpuscular volume (P=0.08) and mean 
562 corpuscular haemoglobin (P=0.09) which tended to decrease with increasing age in the 
563 pigs.
564 Pigs on the post-weaning PRO treatment had higher WBC counts on D57 pw than CON 
565 pigs (14.62 vs 11.68 ± 0.962 ×103 cells/µL; P=0.04).  There was a tendency for a 
566 maternal treatment × post-weaning treatment interaction for the total lymphocyte count 
567 on D57 pw (P=0.10).  An effect of post-weaning treatment was found for the total 
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568 number of lymphocytes and lymphocyte percentage at D57 pw, where PRO pigs had a 
569 higher lymphocyte count and percentage than CON pigs [10.97 vs 7.29 ± 1.145 ×103 
570 cells/µL (P=0.03) and 68.03 vs 59.33 ± 2.954 % (P=0.04), respectively].  Similarly, the 
571 overall lymphocyte count and lymphocyte percentage tended to be higher in PRO 
572 compared to CON pigs [10.61 vs 8.42 ± 0.822 ×103 cells/µL (P=0.06) and 68.95 vs 
573 61.11 ± 2.135 % (P=0.01), respectively].
574 A maternal treatment × post-weaning treatment interaction was found on D8 pw for 
575 monocyte count (P<0.01), with counts lower in the CON/CON group than in the 
576 PRO/CON group.  Likewise, a tendency for a maternal treatment × post-weaning 
577 treatment interaction was also found for the percentage of monocytes on D8 pw 
578 (P=0.09), with piglets from the CON/CON group having a lower percentage than their 
579 PRO/CON counterparts.  This led to offspring from PRO sows having a higher 
580 monocyte percentage than pigs born to CON sows at D8 pw (6.65 vs 4.76 ± 0.667 %; 
581 P=0.05).  In addition, pigs on the post-weaning probiotic treatment had a lower 
582 percentage of monocytes than CON pigs on D57 pw (7.95 vs 10.65 ± 0.873 %; P=0.03) 
583 and overall (6.36 vs 8.28 ± 0.631 %; P=0.04).
584 A maternal treatment × post-weaning treatment interaction was observed at weaning for 
585 the neutrophil count (P=0.05), where pigs from the CON/PRO group had a higher count 
586 than PRO/PRO pigs.  A tendency for a post-weaning treatment effect was observed 
587 overall for the neutrophil percentage, where probiotic-supplemented pigs had a lower 
588 percentage of neutrophils than CON pigs (21.90 vs 26.90 ± 1.877 %; P=0.07).
589 There was a maternal treatment × post-weaning treatment interaction for both the 
590 eosinophil count (P=0.01) and percentage (P=0.001) on D57 pw, with pigs from the 
591 PRO/CON group having a higher eosinophil count and percentage than pigs from the 
592 CON/PRO and PRO/PRO groups.  A post-weaning treatment effect was also observed, 
593 with probiotic-supplemented pigs having lower eosinophil counts than CON pigs on D8 
594 pw (0.11 vs 0.16 ± 0.017 ×103 cells/µL; P=0.03), D57 pw (0.15 vs 0.22 ± 0.019 ×103 
595 cells/µL; P<0.01), and overall (0.15 vs 0.19 ± 0.014 ×103 cells/µL; P=0.050).  
596 Similarly, probiotic-supplemented pigs had a lower eosinophil percentage than CON 
597 pigs on D57 pw (0.95 vs 1.89 ± 0.140 %; P<0.001) and overall (0.97 vs 1.47 ± 0.102 %; 
598 P=0.001).
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599 A maternal treatment × post-weaning treatment interaction was found for basophil count 
600 (P=0.001) and percentage (P=0.02) on D8 pw, with CON/CON pigs having a lower 
601 basophil count and percentage than pigs from CON/PRO and PRO/CON groups.  In 
602 addition, pigs born to CON sows had a lower basophil count than those born to PRO 
603 sows at weaning (0.07 vs 0.12 ± 0.012 ×103 cells/µL; P=0.05) and D8 pw (0.04 vs 0.06 
604 ± 0.006 ×103 cells/µL; P=0.02).  This led to offspring from CON sows having a lower 
605 basophil percentage than those from PRO sows at weaning (0.58 vs 1.16 ± 0.108 %; 
606 P=0.01) and D8 pw (0.37 vs 0.55 ± 0.058 %; P=0.03).  An effect of post-weaning 
607 treatment was also observed for basophil percentage overall, where probiotic- 
608 supplemented pigs had a lower percentage than CON pigs (1.56 vs 2.07 ± 0.179 %; 
609 P=0.05).
610 At weaning, tendencies for a maternal treatment effect were observed for RBC count 
611 (7.82 vs 6.98 ± 0.318 ×106 cells/µL; P=0.07), haemoglobin (15.08 vs 13.64 ± 0.594 
612 g/dL; P=0.10) and haematocrit (0.50 vs 0.45 ± 0.018 L/L; P=0.05), with offspring from 
613 CON sows having higher levels than those from PRO sows.  A tendency for a maternal 
614 treatment × post-weaning treatment interaction was observed for mean corpuscular 
615 haemoglobin at weaning (P=0.10), D57 pw (P=0.08) and overall (P=0.07), and for 
616 mean corpuscular haemoglobin concentration overall (P=0.06).  On D8 pw, PRO-
617 supplemented pigs tended to have a higher mean corpuscular haemoglobin 
618 concentration than CON pigs (28.88 vs 28.43 ± 0.186 g/dL; P=0.10).
619 Regarding platelet counts, a significant maternal effect was found on D8 pw, with the 
620 offspring from CON sows having a lower platelet count than those from PRO sows 
621 (224.25 vs 332.28 ± 22.892 ×103 cells/µL; P<0.01).
622
623 Intestinal morphology of piglets post-weaning
624 There was no maternal treatment × post-weaning treatment interaction (P>0.05) for any 
625 of the intestinal morphological parameters investigated (Supplementary Table S4).  In 
626 addition, there was little effect of post-weaning treatment, except for an increase in 
627 villous height:crypt depth ratio in the jejunum (1.9 to 2.1 ± 0.06; P=0.03) and an 
628 increase in villous area in the ileum (36786 to 42443 ± 1724.3 µm2; P=0.03) in response 
629 to feeding the probiotic post-weaning.  For this reason, only the main effects of 
630 maternal treatment are presented in Table 8.
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631 Pigs born to PRO sows had longer villi (P<0.01), greater villous area (P<0.01), deeper 
632 crypts (P=0.04) and a tendency for greater crypt area (P=0.06) in the duodenum than 
633 pigs born to CON sows (Figure 1).  The offspring from PRO sows also had deeper 
634 crypts (P=0.04) and a greater crypt area (P<0.01) in the jejunum than those from CON 
635 sows.  Ileal villous height (P=0.06) and area (P=0.10) tended to be greater in pigs born 
636 to PRO sows than in the offspring from CON sows.
637
638 Discussion
639 This study assessed the effect of supplementing B. altitudinis WIT588 spores to 
640 transition and lactating sows and/or their offspring on the growth and health of sows 
641 and their offspring.  While a number of probiotic supplementation studies with a similar 
642 design have been published, piglet growth has rarely been determined after the early 
643 post-weaning period(18,20,24,27–29).  The novelty of this study lies in the fact that the 
644 offspring of probiotic-supplemented sows were followed from birth to slaughter.  To 
645 our knowledge, this is the first study to date that conclusively demonstrates lifetime 
646 growth benefits in the offspring of probiotic-supplemented sows.
647 Maternal probiotic supplementation improved FCR of offspring during the first 14 days 
648 post-weaning.  Improved FCR early post-weaning is considered a good indicator of 
649 improved intestinal health at this critical period(39).  This was corroborated in the present 
650 study when increased villous height was found at D8 pw in the small intestine of pigs 
651 born to probiotic-supplemented sows.  This indicates increased absorptive capacity 
652 which may account for the increased lifetime growth in these animals.  In fact, 
653 improved FCR early post-weaning has previously been shown to correlate well with 
654 increased lifetime growth(40).  This held true in the current study.  Incremental increases 
655 in growth in offspring due to maternal probiotic supplementation were observed, with 
656 the initial increases in pig live-weight at D14, D28 and D56 pw not being statistically 
657 significant.  It was only in the late finishing period (D105 and 127 pw) when increased 
658 live-weight in pigs in response to feeding probiotic to the sows became significant.  The 
659 improvement in live-weight at the end of the finishing period resulted in a 3.5 kg 
660 increase in carcass weight in offspring from probiotic-supplemented versus control 
661 sows.
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662 Interestingly, there was no additive effect of post-weaning supplementation of the 
663 offspring from probiotic-supplemented sows, nor were there any benefits of probiotic 
664 supplementation of weaned pigs alone.  This agrees with the findings from a previous 
665 study from our group in which growth benefits in weaned pigs supplemented with this 
666 strain were only found when compared with a medicated diet containing apramycin and 
667 pharmacological levels of zinc oxide, and not when compared with the negative 
668 control(26).  The lack of effect in weaned pigs may be because commencing 
669 supplementation to pigs post-weaning might be too late to see an effect, as it is 
670 understood that there is a critical window early in life during which gut microbiota 
671 modulation is more impactful(41).  Probiotic supplementation of sow diets offers an 
672 effective means of early-life (prior to weaning) probiotic administration, as litters do not 
673 consume appreciable amounts of creep feed until ~D14 of age and oral dosing of 
674 individual piglets prior to this is not feasible on a commercial pig unit.
675 In the present study, B. altitudinis WIT588 was detected as early as D13 of age in 
676 suckling piglets born to sows fed this probiotic strain, even though the probiotic had not 
677 been administered to the piglets themselves.  This demonstrates probiotic transfer from 
678 sows to offspring.  Although, the use of Bacillus strains as probiotics in pig production 
679 is well documented, whether administered to weaned piglets(8,9) or to gestating sows and 
680 their offspring(18,20,24,27–29), few studies have reported probiotic transmission from the 
681 sow to the piglet(27,28).  Although the mechanisms by which the probiotic is vertically 
682 transmitted in the present study are not fully understood, it is most likely via the faecal-
683 oral route(42).  In fact, we hypothesise that Bacillus spores excreted in the sow’s faeces 
684 germinate in the farrowing house environment and, due to the relatively high gastric pH 
685 in suckling piglets(43), survive gastric transit as vegetative cells in the piglets leading to 
686 early colonization of the gut.  This early colonization may also help to explain why 
687 beneficial effects are observed in these animals and not in piglets to which the probiotic 
688 spores are administered post-weaning, as it appears from our previous work that the 
689 spores do not germinate in the gut(26).  Another mechanism by which the probiotic could 
690 be vertically transmitted to the piglets is that the spores might be transferred to the 
691 piglets in dust from the sow feed or indeed via direct contact with the feed, hence 
692 bypassing faecal transplantation from the mother.  However, this potential mechanism 
693 leaves little opportunity for the spores to germinate outside the pig and become 
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694 metabolically active and so is not considered by the authors to be as important as faecal-
695 oral transfer.
696 Similar to the lack of persistence found in weaned piglets, which no longer shed B. 
697 altitudinis WIT588 one month after ceasing probiotic administration, this early 
698 colonization in suckling piglets was also transient.  This is evidenced by the fact that B. 
699 altitudinis WIT588 was not detected in the intestinal digesta of piglets from the 
700 PRO/CON group on D8 pw, i.e. one week after contact with the probiotic-supplemented 
701 mothers had ceased.  This lack of persistence post-administration is not uncommon with 
702 probiotics(12).  In addition, this early colonization in suckling piglets was not at as high a 
703 level or as consistent as when the probiotic was directly administered to weaned piglets.  
704 Not all of the piglets born to probiotic-supplemented sows shed B. altitudinis WIT588 
705 at both time points prior to weaning, and some of those that shed the probiotic at D13 
706 were no longer doing so at D26.  However, the probiotic was recovered from all of the 
707 piglets at some point prior to weaning, and the differences in shedding may be due to 
708 variations in the level of probiotic to which the piglets were exposed and also to 
709 variations in gastric pH(43) or coprophagic behaviour(44).
710 One possible mechanism by which the probiotic strain improved lifetime growth of the 
711 progeny of the sows to which it was administered is via modulation of colostrum 
712 composition.  Although all of the measured colostrum and milk compositional values 
713 fell within reference ranges(45), the colostrum from probiotic-fed sows had a higher 
714 protein content than that from control sows, indicating that it was of higher nutritional 
715 value(46).  In previous studies, protein, together with fat content, of milk was also 
716 increased as a result of Bacillus supplementation of sows(9,30), although others reported 
717 only an increase in fat content(18).  The higher protein content of the colostrum from the 
718 probiotic-supplemented sows in the current study may have resulted from increased 
719 mobilisation of the sows’ body reserves as these sows were lighter than control sows on 
720 the weaning day and lost more weight (numerically) during the lactation period.  
721 However, probiotic-supplemented sows also had to produce more milk during lactation, 
722 as they suckled more piglets to weaning.  Furthermore, we do not know the exact 
723 mechanism by which probiotic supplementation increased colostrum protein content.  
724 Another avenue that we explored was that higher concentrations of immunoglobulins in 
725 the colostrum of probiotic-supplemented sows would confer increased immune 
726 protection to offspring, thereby helping to explain the observed growth benefits, the 
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727 numerical reduction in pre-weaning mortality and the improved intestinal morphology 
728 found in piglets born to probiotic-supplemented sows.  However, maternal probiotic 
729 supplementation did not have a significant effect on the concentrations of IgA or IgG in 
730 the colostrum.  
731 Interestingly, some of the haematological parameters measured in sows indicate a 
732 possible inflammatory response after the first 2 weeks of probiotic treatment (D114 of 
733 gestation) which persisted throughout the suckling period.  Basophil counts in probiotic-
734 supplemented sows were higher than those in control sows, although all values were 
735 within reference ranges, except the basophil percentage at weaning (the upper limit is 
736 2.0% and the value in probiotic-supplemented sows was 2.32%)(47).  Probiotic-
737 supplemented sows also had lower mean corpuscular volume and less mean corpuscular 
738 haemoglobin than control sows from farrowing to weaning but values were within the 
739 normal ranges, being indicative of subtle anaemia or possible inflammation.  This 
740 possible immune modulation in the sow could have affected the pigs in utero (despite 
741 swine placenta being epitheliochorial), which may also help to explain the improved gut 
742 health early post-weaning and the subsequent growth benefits.  It has previously been 
743 reported that Bacillus spores can trigger immune responses in the gut(48,49), which may 
744 protect against external pathogens.  However, specific immune assays in intestinal cells 
745 are required in order to further investigate the probiotic-mediated immunomodulation 
746 hypothesised in the current study.
747 It is interesting to note that some of the haematological effects found in the sows were 
748 mirrored in the offspring.  For example, piglets born to probiotic-fed sows had higher 
749 basophil counts and percentages than the offspring from control sows on the day of 
750 weaning and at D8 pw.  This may have been caused by an in utero effect or it could be 
751 indicative of immune stimulation during the early stages of suckling due to early-life 
752 probiotic exposure.  Nonetheless, this effect diminished after D8 pw and was not 
753 observed thereafter.  There was no effect of post-weaning treatment with the probiotic 
754 on the haematology of pigs; however, piglets that were never exposed to B. altitudinis 
755 WIT588 had the lowest levels of basophils.  Other significant differences of note were 
756 the effects on WBC populations found due to probiotic administration post-weaning.  
757 These included elevated total WBC and lymphocyte counts and reduced monocyte and 
758 eosinophil levels, albeit all were within reference values(50).  Interestingly, all were 
759 observed two months post-weaning (D57 pw).  However, it is difficult to explain these 
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760 differences, because at this stage the piglets were no longer shedding B. altitudinis 
761 WIT588.  The effects may however be residual.  In any case, these post-weaning 
762 treatment-related haematological effects did not translate into improved growth, 
763 highlighting the fact that maternal supplementation is the preferred route of 
764 administration to pigs for this probiotic strain.
765
766 Conclusions
767 The data presented in this study indicate that B. altitudinis WIT588 dietary 
768 supplementation to sows during late gestation and lactation is more beneficial than post-
769 weaning administration to piglets.  Piglets born to sows supplemented with the probiotic 
770 displayed faecal shedding of the administered strain while suckling.  This vertical 
771 transmission is rarely reported for other probiotics and demonstrates that maternal 
772 supplementation is an effective means of early-life probiotic administration.  Maternal 
773 treatment improved feed efficiency in the early post-weaning period in progeny and 
774 increased live-weight at the end of the finishing period, which resulted in increased 
775 carcass weight at target slaughter age.  Possible mechanisms of action are improved 
776 colostrum quality in sows, maternal immunomodulation, which was mirrored to a 
777 certain extent in the offspring, and increased small intestinal absorptive capacity in 
778 offspring early post-weaning.  However, further analyses are needed to elucidate the 
779 mechanism(s) of action, including serum immunoglobulin measurements.  In summary, 
780 the novelty of this study lies in the fact that the offspring of probiotic-supplemented 
781 sows were followed from birth to slaughter.  The lifetime growth benefits observed 
782 offer considerable economic advantages for commercial pig producers in search of 
783 alternatives to in-feed antibiotics and pharmacological levels of zinc oxide.  Work is 
784 ongoing to develop a product containing spray/freeze dried spores to facilitate 
785 formulation of the probiotic strain into commercial pig diets. 
786
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Table 1. Composition of experimental diets (on an air-dry basis; kg/tonne unless 
otherwise stated).
Item Dry Sow Lactating Sow Starter/link Weaner Finisher
Barley 753.02 269.81 62.86 257.58 384.67
Wheat 0 429.6 112 433.57 400
Maize 0 0 300 0 0
Soybean meal 89.62 196.65 255 187.92 183.01
Soya hulls 121.8 0 0 0 0
Full fat soya 0 0 70 50 0
Lactoflo1 0 0 100 0 0
Skim milk powder 0 0 25 0 0
Soya oil 11 66 40 40 9.69
Lysine HCl 2.19 4.47 5.14 5.02 3.75
DL-Methionine 0.58 1.35 2.62 1.85 0.93
L-Threonine 0.6 2.45 2.55 2.09 1.7
L-Tryptophan 0 0.71 0.97 0.27 0.15
L-Valine 0 2.34 0.26 0 0
Vitamin and mineral mix 1.52 1.52 33 33 14
Salt feed grade 4 5 3 3 3
Mono di-calcium phosphate 6.49 8.5 9.5 4.6 1
Limestone flour 9.08 11.5 8 11 11
Phytase5 0.1 0.1 0.1 0.1 0.1
Analysed chemical composition
Dry matter 875 898 891 897 876
Crude protein 129 164 190 193 171
Fat 36.6 102.8 65.1 72.1 43.5
Crude fibre 72 26 30 27 31
Neutral detergent fibre 162 82 88 84 103
Ash 40 48 48 45 43
Lysine 8.2 11.5 15.0 13.0 11.0
Methionine 2.7 3.8 5.8 4.6 3.5
Methionine and cysteine 5.4 7.0 9.1 7.9 6.7
Threonine 5.5 8.3 10.1 8.6 7.7
Tryptophan 1.7 2.8 3.4 2.6 2.3
Calculated chemical composition6
Standardised ileal digestible lysine 6.60 10.67 14.00 11.49 9.97
Calcium 7.20 8.32 8.00 7.25 6.59
Digestible phosphorus 3.45 3.88 4.44 3.32 2.55
Digestible energy (MJ/kg) 13.2 15.2 15.0 14.5 13.8
Net energy (MJ/kg) 8.9 10.9 10.74 10.55 9.80
1Lactoflo 70 contains 70% lactose, 11.5% protein, 0.5% oil, 7.5% ash and 0.5% fibre (Volac, 
Cambridge, UK).
2Premix provided per kg of complete diet: Cu, 15 mg; Fe, 70 mg; Mn, 62 mg; Zn, 80 mg; I, 0.6 
mg; Se, 0.2 mg; vitamin A, 1000 IU; vitamin D3, 1000 IU; vitamin E, 100 IU; vitamin K, 2 mg; 
vitamin B12, 15 μg; riboflavin, 5 mg; nicotinic acid, 12 mg; pantothenic acid, 10 mg; choline 
chloride, 500 mg; biotin, 200 mg; folic acid, 5 g; vitamin B1, 2 mg; vitamin B6, 3 mg. 
3Premix provided per kg of complete diet: Cu, 155 mg; Fe, 90 mg; Mn, 47 mg; Zn, 120 mg; I, 
0.6 mg; Se, 0.3 mg; vitamin A, 6000 IU; vitamin D3, 1000 IU; vitamin E, 100 IU; vitamin K, 4 
mg; vitamin B12, 15 μg; riboflavin, 2 mg; nicotinic acid, 12 mg; pantothenic acid, 10 mg; 
choline chloride, 250 mg; vitamin B1, 2 mg; vitamin B6, 3 mg; Endox, 60 g. 
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4Premix provided per kg of complete diet: Cu, 15 mg; Fe, 24 mg; Mn, 31 mg; Zn, 80 mg; I, 0.3 
mg; Se, 0.2 mg; vitamin A, 2000 IU; vitamin D3, 500 IU; vitamin E, 40 IU; vitamin K, 4 mg; 
vitamin B12, 15 μg; riboflavin, 2 mg; nicotinic acid, 12 mg; pantothenic acid, 10 mg; vitamin B1, 
2 mg; vitamin B6, 3 mg. 
5The diet contained 500 phytase units (FYT) per kg feed from RONOZYME HiPhos (DSM, 
Belfast, UK).
6Calculated from tabulated ingredient values(51).
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Table 2. Effect of supplementing sow diets with Bacillus altitudinis WIT588 spores 
from day (D) 100 of gestation to weaning (D26 of lactation) on faecal counts (log10 




















D100 Gestation 3.004 (0/12) 3.00 (0/12) - - -
D115 Gestation 3.08 (1/12) 5.93 (12/12) 0.047 <0.001
D13 Lactation 3.00 (0/12) 6.39 (12/12) 0.047 <0.001
Weaning (D26 
Lactation) 3.00 (0/12) 6.17 (12/12) 0.047 <0.001
Overall 0.034 <0.001 <0.001 <0.001
Piglets during lactation
N 20 20
D135 3.00 (0/20) 3.47 (12/20) 0.075 <0.001
D266 3.00 (0/20) 4.79 (16/20) 0.080 <0.001
Overall 0.055 <0.001 <0.001 <0.001
1Least square means and pooled standard errors of the mean (SEM).
2CON: non-probiotic supplemented sows; 3PRO: probiotic-supplemented sows.
4The limit of detection of the assay for B. altitudinis WIT588 was 1000 CFU/g faeces or /swab. 
Values below the limit of detection were recorded as 3.00 log10 CFU/g faeces or /swab.
5Counts are from rectal swabs and are presented as log10 CFU/swab.
6A rectal swab was taken from three pigs in the probiotic treatment group due to insufficient 
faecal sample. Probiotic was detected in these animals but the counts were excluded from the 
statistical analysis. 
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Table 3. Effect of supplementing sow diets with Bacillus altitudinis WIT588 spores 
from day (D) 100 of gestation to weaning (D26 of lactation) on haematological 
parameters of sows1.
Treatment P-value







G100 0.10 0.11 0.013 0.54Basophils (×103 
cells/µL) G114 0.11 0.17 0.024 0.04
W26 0.17 0.22 0.022 0.07
Mean 0.14 0.20 0.018 <0.01 <0.01 0.72
Basophils (%)4 G100 1.11 1.36 0.127 0.19
G114 1.24 1.81 0.207 0.05
W26 1.58 2.32 0.188 <0.01
Mean 1.41 2.06 0.155 0.001 0.02 0.61
G100 63.52 62.77 0.601 0.25Mean corpuscular 
volume (fL) G114 66.18 63.88 0.474 0.001
W26 65.01 63.23 0.431 <0.01
Mean 65.60 63.55 0.357 <0.001 0.03 0.51
G100 19.90 19.57 0.197 0.13
G114 20.47 19.93 0.154 0.01
Mean corpuscular 
haemoglobin 
(pg/cell) W26 20.20 19.54 0.139 0.001
Mean 20.34 19.74 0.113 0.001 0.02 0.65
G100 31.33 31.14 0.220 0.56
G114 30.89 31.23 0.122 0.04




Mean 30.96 31.12 0.093 0.14 0.62 0.09
G100: Day 100 of gestation; G114: day 114 of gestation; W26: weaning (day 26 of lactation).
1Least square means and pooled standard errors of the mean (SEM).
2CON: non-probiotic supplemented sows; 3PRO: probiotic-supplemented sows.
4Percentages are based on the differential count of white blood cells.
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Table 4. Effect of supplementing sow diets with Bacillus altitudinis WIT588 spores 
from day (D) 100 of gestation to weaning (D26 of lactation) on the composition of 
sow colostrum and milk1.
Treatment
CON2 PRO3 SEM P-value 
N 12 12
Colostrum 
Total solids (%) 21.97 24.01 0.581 0.02
Lactose (%) 2.06 1.52 0.128 <0.01
Fat (%) 3.94 4.14 0.430 0.75
Protein (%) 14.25 16.56 0.759 0.04
True protein (%) 13.83 16.18 0.791 0.05
Casein B (%) 11.98 14.08 0.717 0.05
Immunoglobulin A (mg/ml) 18.06 21.40 3.120 0.46
Immunoglobulin G (mg/ml) 79.79 96.42 12.157 0.34
Milk4 
Total solids (%) 18.91 18.56 0.500 0.63
Lactose (%) 5.23 5.22 0.130 0.93
Fat (%) 7.42 6.74 0.524 0.37
Protein (%) 4.78 4.89 0.116 0.49
True protein (%) 4.25 4.41 0.115 0.34
Casein B (%) 3.34 3.47 0.111 0.45
1Least square means and pooled standard errors of the mean (SEM).
2CON: non-probiotic supplemented sows; 3PRO: probiotic-supplemented sows.
4Milk was sampled 14 days post-partum.
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Table 5. Effect of Bacillus altitudinis WIT588 spore supplementation to sow and piglet diets on post-weaning growth and carcass 
characteristics1.
Maternal Control Control Probiotic Probiotic P-value
Post-weaning (pw) Control Probiotic Control Probiotic




× pw × 
Day
N 18 18 18 18
Mortality6 0 1 0 0
Off trial7 2 2 2 0
Body weight (kg) 0‡ 8.1 8.7 8.1 8.4 0.36 0.62 0.16 0.72
14 11.8 10.9 11.8 11.3 1.31 0.89 0.57 0.95
28 18.8 17.4 18.9 18.6 1.32 0.62 0.50 0.84
56 44.4 40.5 42.9 43.1 1.34 0.68 0.16 0.23
105 92.7AB 90.8A 95.1AB 95.4B 1.39 0.01 0.55 0.07
127 121.1A 120.9A 123.4AB 125.6B 1.38 0.01 0.47 0.05
Overall 0.60 <0.01 0.27 0.09 <0.001 0.88
ADG (g/day) 0-14 229 200 232 210 24.9 0.80 0.31 0.77
15-28 502 465 509 519 25.1 0.22 0.60 0.47
29-56 910 818 862 874 25.5 0.87 0.13 0.10
57-105 1019 1030 1065 1067 26.5 0.12 0.80 0.46
106-127 1303 1365 1365 1375 26.3 0.17 0.17 0.19
Overall 11.5 0.04 0.55 0.40 <0.001 0.26
0-127 897 883 921 924 15.5 0.04 0.73 0.60
ADFI (g/day) 0-14 303 282 284 271 42.0 0.72 0.68 0.96
15-28 641 600 648 637 42.3 0.61 0.54 0.86
29-56 1353 1193 1259 1288 43.0 0.99 0.13 0.08
57-105 2293 2170 2288 2300 44.7 0.17 0.21 0.14
106-127 3230 3273 3309 3336 44.3 0.11 0.43 0.35
Overall 19.4 0.15 0.19 0.08 <0.001 0.38
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Maternal Control Control Probiotic Probiotic P-value
Post-weaning (pw) Control Probiotic Control Probiotic




× pw × 
Day
0-127 1874 1795 1884 1883 33.7 0.15 0.24 0.26
Feed conversion ratio (g/g) 0-14 1.37ab 1.53a 1.22b 1.33ab 0.042 <0.001 <0.01 <0.001
15-28 1.28 1.31 1.28 1.23 0.042 0.35 0.78 0.63
29-56 1.49 1.45 1.47 1.47 0.043 0.95 0.69 0.94
57-105 2.26 2.09 2.16 2.16 0.045 0.68 0.06 0.07
106-127 2.51 2.39 2.46 2.46 0.044 0.91 0.18 0.33
Overall 0.019 0.02 0.70 0.28 <0.001 0.22
 0-127 2.09 2.03 2.05 2.04 0.019 0.41 0.07 0.19   
Carcass characteristics 
Carcass weight (kg) 91.7 90.1 93.0 95.9 1.73 0.05 0.71 0.21
Kill out (%) 75.1 75.0 75.5 76.3 0.27 <0.01 0.15 0.13
Lean meat (%) 53.8 54.6 54.6 54.0 0.47 0.86 0.81 0.15
Muscle (mm) 47.7 48.7 51.8 49.7 1.61 0.12 0.73 0.34
Fat (mm) 16.0 15.1 15.8 16.0 0.60 0.51 0.58 0.33
ADG: average daily gain; ADFI: average daily feed intake.
1Least square means and pooled standard errors of the mean (SEM).
2CON/CON, non-probiotic supplemented sow/non-probiotic supplemented piglet; 3CON/PRO, non-probiotic supplemented sow/probiotic-supplemented 
piglet; 4PRO/CON, probiotic-supplemented sow/non-probiotic supplemented piglet; 5PRO/PRO, probiotic-supplemented sow/probiotic-supplemented piglet.
6Mortality: Due to polyserositis and septicaemia (Streptococcus suis infection).
7Off trial: Pigs were removed from the trial due to lameness (PRO/CON, N=1), pneumonia (CON/CON, N=1 and CON/PRO, N=1), bloody diarrhoea 
(CON/CON, N=1 and PRO/CON, N=1) and abdominal hernia (CON/PRO, N=1).
a-bValues within a row that do not share a common superscript are significantly different (P≤0.05).
A-BValues within a row that do not share a common superscript tended to differ (P≤0.10).
‡Day 0 pw is the day of weaning.
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Table 6. Effect of Bacillus altitudinis WIT588 spore supplementation to sow and piglet diets on ileal, caecal and rectal digesta counts 
(log10 CFU/g)1 of piglets euthanized on day (D) 8 post-weaning and on faecal counts at D0, D27 and D56 post-weaning.
Maternal Control Control Probiotic Probiotic P-value
Post-weaning (pw) Control Probiotic Control Probiotic
CON/CON2




























Maternal pw Maternal × pw Day
Maternal × 
pw × Day
N 10 10 10 10
Ileum (D8 pw) 3.006 (0/10) 5.13 (10/10) 3.00 (0/10) 5.13 (9/10) 0.153 0.99 <0.001 0.99
Caecum (D8 pw) 3.00 (0/10) 5.48 (10/10) 3.00 (0/10) 5.37 (10/10) 0.114 0.62 <0.001 0.62
Rectum (D8 pw) 3.00 (0/10) 5.97 (10/10) 3.00 (0/10) 6.07 (10/10) 0.065 0.44 <0.001 0.44
N 10 10 10 10
Weaning (D0 pw) 3.00A (0/10) 3.00A (0/10) 4.47B (8/10) 4.93C (8/10) 0.124 <0.001 0.08 0.08
D27 pw 3.00a (0/10) 5.95b (10/10) 3.00a (0/10) 5.91b (10/10) 0.033 0.85 <0.001 <0.001
D56 pw 3.00 (0/10) 3.00 (0/10) 3.00 (0/10) 3.00 (0/10) 0.033 0.63 0.96 0.97
Overall 0.025 0.87 <0.001 0.57 <0.001 0.52
1Least square means and pooled standard errors of the mean (SEM).
2CON/CON, non-probiotic supplemented sow/non-probiotic supplemented piglet; 3CON/PRO, non-probiotic supplemented sow/probiotic-supplemented 
piglet; 4PRO/CON, probiotic-supplemented sow/non-probiotic supplemented piglet; 5PRO/PRO, probiotic-supplemented sow/probiotic-supplemented piglet.
6The limit of detection of the assay for B. altitudinis WIT588 was 1000 CFU/g faeces. Values below the limit of detection were recorded as 3.00 log10 CFU/g 
faeces.
a-bValues within a row that do not share a common superscript are significantly different (P≤0.05).
A-CValues within a row that do not share a common superscript tended to differ (P≤0.10).
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Table 7. Effect of Bacillus altitudinis WIT588 spore supplementation to sow and piglet diets on haematological parameters of piglets at 
weaning and day 8, 28 and 57 post-weaning1.
Maternal Control Control Probiotic Probiotic P-value
Post-weaning (pw) Control Probiotic Control Probiotic
Day 




× pw × 
Day
0‡ 10.51 13.37 11.94 9.83 1.390 0.47 0.85 0.08
8 12.76 11.92 13.63 10.22 1.555 0.74 0.17 0.40
28 15.66 15.40 13.33 13.55 1.522 0.18 1.00 0.60
57 10.34 14.05 13.20 15.23 1.363 0.13 0.04 0.08
White blood cells 
(×103/μl)
Mean 12.73 14.71 13.26 14.37 1.159 0.92 0.19 0.70 0.11 0.43
0 5.12 6.56 6.11 5.76 1.121 0.94 0.63 0.43
8 7.75 6.98 7.68 5.88 1.331 0.63 0.33 0.67
28 10.44 10.75 8.67 9.76 1.667 0.41 0.68 0.81
57 5.99 10.40 8.59 11.54 1.619 0.25 0.03 0.10
Lymphocytes (×103 
cells/µL)
Mean 8.21 10.57 8.63 10.65 1.162 0.83 0.06 0.89 0.51 0.63
0 50.58 47.86 54.11 52.73 6.077 0.49 0.79 0.91
8 57.96 53.29 57.04 55.48 5.473 0.90 0.57 0.78
28 65.49 71.52 60.29 68.23 4.348 0.34 0.11 0.29
57 59.30 66.80 59.37 69.26 4.180 0.76 0.04 0.22
Lymphocytes (%)6
Mean 62.39 69.16 59.83 68.74 3.027 0.63 0.01 0.72 0.37 0.97
0 0.71 0.81 0.88 0.63 0.130 0.89 0.54 0.17
8 0.45a 0.77ab 1.00b 0.58ab 0.123 0.16 0.96 <0.01
28 0.83 0.67 0.76 0.69 0.135 0.85 0.42 0.86
57 1.10 1.17 1.20 1.05 0.130 0.91 0.78 0.84
Monocytes (×103 
cells/µL)
Mean 0.96 0.92 0.98 0.87 0.094 0.83 0.44 0.72 <0.001 0.41
0 6.44 6.32 7.06 7.49 1.063 0.41 0.90 0.80Monocytes (%)6
8 3.78A 5.99AB 7.08B 6.24AB 0.955 0.05 0.32 0.09
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Maternal Control Control Probiotic Probiotic P-value
Post-weaning (pw) Control Probiotic Control Probiotic
Day 




× pw × 
Day
28 5.89 4.55 5.93 4.99 1.286 0.85 0.38 0.83
57 11.34 8.59 9.97 7.30 1.236 0.29 0.03 0.13
Mean 8.62 6.57 7.95 6.15 0.895 0.55 0.04 0.89 <0.001 0.93
0 4.43AB 5.75A 4.66AB 3.21B 0.714 0.10 0.72 0.05
8 4.36 3.99 3.85 3.62 0.519 0.40 0.58 0.92
28 4.13 3.43 3.47 2.98 0.407 0.19 0.15 0.30
57 2.85 3.07 3.21 2.78 0.392 0.93 0.79 0.86
Neutrophils (×103 
cells/µL)
Mean 3.49 3.25 3.34 2.88 0.285 0.38 0.22 0.70 0.07 0.45
0 40.69 43.98 36.20 36.98 5.059 0.26 0.69 0.81
8 36.81 38.02 34.10 36.84 4.676 0.68 0.67 0.86
28 25.63 22.04 30.54 23.98 3.393 0.33 0.14 0.31
57 25.15 21.09 26.27 20.49 3.270 0.94 0.14 0.51
Neutrophils (%)6
Mean 25.39 21.57 28.41 22.24 2.671 0.50 0.07 0.66 0.26 0.88
0 0.17 0.19 0.16 0.14 0.035 0.38 0.98 0.65
8 0.16 0.13 0.17 0.09 0.024 0.42 0.03 0.29
28 0.19 0.17 0.13 0.15 0.028 0.22 0.99 0.59
57 0.19AB 0.14A 0.26B 0.15A 0.027 0.14 <0.01 0.01
Eosinophils (×103 
cells/µL)
Mean 0.19 0.15 0.20 0.15 0.019 0.888 0.05 0.71 0.19 0.19
0 1.63 1.31 1.47 1.63 0.291 0.78 0.77 0.41
8 1.20 1.14 0.94 0.93 0.151 0.13 0.82 0.90
28 1.15 1.09 0.94 0.89 0.206 0.34 0.78 0.81
57 1.72ab 0.89a 2.06b 1.02a 0.198 0.23 <0.001 0.001
Eosinophils (%)6
Mean 1.43 0.99 1.50 0.95 0.145 0.903 0.001 0.72 <0.01 0.71
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Maternal Control Control Probiotic Probiotic P-value
Post-weaning (pw) Control Probiotic Control Probiotic
Day 




× pw × 
Day
0 0.09 0.06 0.16 0.10 0.024 0.05 0.11 0.70
8 0.03a 0.06b 0.08b 0.05ab 0.009 0.02 0.69 0.001
28 0.23 0.15 0.26 0.21 0.039 0.27 0.13 0.27
57 0.27 0.28 0.24 0.22 0.038 0.22 0.88 0.63
Basophils (×103 
cells/µL)
Mean 0.25 0.22 0.25 0.22 0.027 0.95 0.23 0.98 0.13 0.57
0 0.66 0.51 1.15 1.16 0.230 0.01 0.64 0.61
8 0.26a 0.54b 0.60b 0.51ab 0.085 0.03 0.11 0.02
28 1.76 1.13 2.02 1.46 0.369 0.44 0.11 0.34
57 2.56 2.10 1.92 1.56 0.355 0.11 0.24 0.26
Basophils (%)6
Mean 2.16 1.61 1.97 1.51 0.259 0.59 0.05 0.87 0.08 0.98
0 7.94 7.71 7.02 6.93 0.450 0.07 0.72 0.88
8 7.10 7.03 7.25 7.15 0.190 0.48 0.64 0.94
28 7.03 7.20 7.09 7.16 0.173 0.96 0.48 0.90
57 7.19 7.22 7.01 7.19 0.169 0.56 0.53 0.81
Red blood cells (×106 
cells/µL)
Mean 7.11 7.21 7.05 7.18 0.151 0.77 0.45 0.93 0.68 0.44
0 15.36 14.79 13.38 13.90 0.840 0.10 0.98 0.52
8 12.92 12.89 12.96 13.03 0.307 0.77 0.95 0.87
28 12.10 12.45 12.26 12.72 0.280 0.45 0.15 0.47
57 12.99 12.45 12.31 12.84 0.270 0.59 0.99 0.25
Haemoglobin (g/dL)
Mean 12.55 12.45 12.29 12.78 0.195 0.86 0.31 0.13 0.18 0.22
0 0.51 0.49 0.44 0.46 0.024 0.05 0.98 0.55
8 0.45 0.45 0.46 0.45 0.011 0.90 0.61 0.76
28 0.40 0.42 0.41 0.42 0.010 0.48 0.15 0.48
Haematocrit (L/L)
57 0.43 0.42 0.41 0.43 0.010 0.67 0.83 0.58
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Maternal Control Control Probiotic Probiotic P-value
Post-weaning (pw) Control Probiotic Control Probiotic
Day 




× pw × 
Day
Mean 0.42 0.42 0.41 0.43 0.009 0.87 0.33 0.53 0.20 0.15
0 63.79 63.87 63.19 66.08 0.904 0.39 0.11 0.13
8 64.02 64.34 63.04 62.72 1.151 0.27 0.99 0.78
28 57.19 58.17 58.10 59.18 0.762 0.22 0.19 0.37
57 59.81 57.71 58.64 59.39 0.747 0.73 0.37 0.23
Mean corpuscular 
volume (fL)
Mean 58.48 57.94 58.37 59.28 0.651 0.35 0.78 0.27 0.07 0.08
0 19.38 19.25 19.12 20.12 0.328 0.37 0.20 0.10
8 18.22 18.42 17.86 18.26 0.325 0.43 0.36 0.75
28 17.16 17.28 17.25 17.75 0.233 0.24 0.20 0.31




Mean 17.61 17.26 17.38 17.79 0.204 0.49 0.89 0.07 <0.01 0.09
0 30.37 30.15 30.29 30.45 0.307 0.72 0.92 0.54
8 28.50 28.65 28.37 29.12 0.264 0.53 0.10 0.27
28 29.98 29.70 29.70 29.93 0.191 0.90 0.90 0.60




Mean 30.12 29.78 29.78 29.99 0.137 0.64 0.64 0.06 0.18 0.96
0 318.10 351.50 426.70 406.80 50.627 0.11 0.90 0.60
8 228.06 220.50 386.20 285.89 32.594 <0.01 0.16 0.26
28 362.07 371.50 349.61 345.03 34.682 0.58 0.95 0.94
57 289.40 262.96 285.10 349.16 27.984 0.16 0.58 0.21
Platelets (×103 
cells/µL)
Mean 323.70 312.55 315.71 347.09 25.040 0.61 0.70 0.41 <0.01 0.15
1Least square means and pooled standard errors of the mean (SEM).
2CON/CON, non-probiotic supplemented sow/non-probiotic supplemented piglet; 3CON/PRO, non-probiotic supplemented sow/probiotic-supplemented 
piglet; 4PRO/CON, probiotic-supplemented sow/non-probiotic supplemented piglet; 5PRO/PRO, probiotic-supplemented sow/probiotic-supplemented piglet.
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6Percentages are based on the differential count of white blood cells.
a-bValues within a row that do not share a common superscript are significantly different (P≤0.05).
A-BValues within a row that do not share a common superscript tended to differ (P≤0.10).
‡Day 0 pw is the day of weaning.
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Table 8. Effect of supplementing sow diets with Bacillus altitudinis WIT588 spores from day (D) 100 of gestation to weaning (D26 of 
lactation) on small intestinal morphology of piglets at D8 post-weaning1.
 Maternal treatment  
CON2 PRO3 SEM P-value
N 20 20
Duodenum
Goblet cells 13.8 14.9 1.14 0.52
Villous height (µm) 351.8 392.7 8.61 <0.01
Crypt depth(µm) 177.0 190.5 4.43 0.04
VH:CD ratio4 2.1 2.1 0.07 0.62
Villous area (µm2) 40888 48962 1814.2 <0.01
Crypt area (µm2) 6739 7485 269.3 0.06
Jejunum
Goblet cells 8.7 10.2 0.85 0.20
Villous height (µm) 346.3 362.8 8.07 0.16
Crypt depth(µm) 175.9 189.1 4.44 0.04
VH:CD ratio4 2.0 2.0 0.06 0.37
Villous area (µm2) 38947 42105 1961.2 0.26
Crypt area (µm2) 6731 8075 343.7 <0.01
Ileum
Goblet cells 13.7 15.9 1.27 0.22
Villous height (µm) 325.7 345.8 7.39 0.06
Crypt depth(µm) 183.1 187.0 3.98 0.50
VH:CD ratio4 1.8 1.9 0.05 0.41
Villous area (µm2) 37552 41677 1724.3 0.10
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Crypt area (µm2) 7211 7659 290.6 0.28
1Least square means and pooled standard errors of the mean (SEM).
2CON: non-probiotic supplemented sows; 3PRO: probiotic-supplemented sows.
4VH:CD ratio, villous height:crypt depth ratio.
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Figure 1. Intestinal morphology of duodenum sections taken on day 8 post-weaning 
from piglets born to sows receiving the B. altitudinis WT588-supplemented diet (A) or 
a control diet (B). The black line shows the villous height measurement. Boxplots show 
the significant effects of the maternal treatment on the crypt depth (C) and villous 
height (D) of the duodenum of the offspring. Significant differences between treatments 
are indicated as ** (P≤0.01) and * (0.01<P≤0.05).
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Supplementary Table S1. Effect of supplementing sow diets with Bacillus 
altitudinis WIT588 spores from day (D) 100 of gestation to weaning (D26 of 
lactation) on tissue mobilisation and reproductive performance of sows1.
  Treatment  P-value







Body weight (kg) D100 Gestation 257.10 258.61 9.337 0.84
D114 Gestation 283.47 278.77 2.769 0.23
D26 Lactation4 256.97 248.68 2.709 0.03
Overall 1.991 0.02 <0.001 0.51
Back fat (mm) D100 Gestation 17.29 18.61 0.784 0.24
D114 Gestation 17.01 17.38 0.413 0.53
D26 Lactation 14.80 14.35 0.405 0.43
Overall 0.300 0.92 <0.001 0.31
Feed intake (kg) Gestation 2.89 2.90 0.096 0.97
Lactation 5.75 5.84 0.096 0.51
Overall 0.068 0.62 <0.001 0.66
Body weight reduction (%)5 9.89 11.48 1.292 0.24
Back fat reduction (%)5 6.38 8.21 3.923 0.62
Reproductive performance
Gestation length (days) 114.76 114.59 0.331 0.689
Total born 14.62 15.49 1.253 0.560
Live born 13.50 13.97 1.170 0.735
Live born (%) 93.32 90.76 3.247 0.543
Stillborn 1.15 1.51 0.592 0.648
Piglets suckling at 48h post-partum 14.26 14.17 0.398 0.871
Mortality (%)6 15.61 10.14 2.815 0.183
Weaned piglets 11.75 12.58 0.548 0.294
1Least square means and pooled standard errors of the mean (SEM).
2CON: non-probiotic supplemented sows; 3PRO: probiotic-supplemented sows.
4Day 26 of lactation was the day that litters were weaned.
5Body weight reduction and back fat reduction were calculated for the entire lactation period.
6Mortality percentage was calculated for the entire pre-weaning period.
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Supplementary Table S2. Effect of supplementing sow diets with Bacillus 
altitudinis WIT588 spores from day (D) 100 of gestation to weaning (D26 of 
lactation) on haematological parameters of sows1.
Treatment P-value





G100 9.08 9.77 0.754 0.53White blood cells 
(×103 cells/μl) G114 8.37 8.90 0.659 0.56
W26 11.00 9.93 0.571 0.18
Mean 9.68 9.42 0.454 0.66 <0.01 0.19
G100 4.32 4.15 0.386 0.76Lymphocytes (×103 
cells/µL) G114 3.31 3.88 0.255 0.11
W26 3.86 3.51 0.229 0.26
Mean 3.58 3.69 0.182 0.64 0.70 0.05
Lymphocytes (%)4 G100 45.83 46.74 2.370 0.79
G114 39.02 43.08 2.586 0.28
W26 36.27 36.37 2.319 0.98
Mean 37.65 39.73 1.739 0.41 0.06 0.43
G100 0.66 0.80 0.087 0.20Monocytes (×103 
cells/µL) G114 0.69 0.65 0.058 0.55
W26 0.67 0.71 0.051 0.62
Mean 0.68 0.68 0.042 0.89 0.70 0.43
Monocytes (%)4 G100 8.04 8.63 0.516 0.43
G114 8.22 7.57 0.563 0.40
W26 6.40 7.36 0.506 0.17
Mean 7.31 7.46 0.405 0.77 0.05 0.12
G100 3.45 3.32 0.355 0.79Neutrophils (×103 
cells/µL) G114 3.99 3.67 0.571 0.70
W26 5.67 4.64 0.505 0.17
Mean 4.83 4.16 0.384 0.23 0.02 0.52
Neutrophils (%)4 G100 37.28 37.05 2.602 0.95
G114 47.04 40.74 2.990 0.15
W26 51.00 49.05 2.646 0.61
Mean 49.02 44.90 2.001 0.16 0.04 0.45
G100 0.44 0.50 0.045 0.32
G114 0.35 0.37 0.073 0.82Eosinophils (×10
3 
cells/µL) W26 0.47 0.40 0.066 0.45
Mean 0.41 0.39 0.052 0.74 0.26 0.50
Eosinophils (%)4 G100 4.59 5.58 0.439 0.13
G114 4.08 4.11 0.639 0.97
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W26 4.29 3.90 0.571 0.63
Mean 4.19 4.01 0.429 0.77 1.00 0.73
G100 0.10 0.11 0.013 0.54Basophils (×103 
cells/µL) G114 0.11 0.17 0.024 0.04
W26 0.17 0.22 0.022 0.07
Mean 0.14 0.20 0.018 <0.01 <0.01 0.72
Basophils (%)4 G100 1.11 1.36 0.127 0.19
G114 1.24 1.81 0.207 0.05
W26 1.58 2.32 0.188 <0.01
Mean 1.41 2.06 0.155 0.001 0.02 0.61
G100 7.36 6.99 0.534 0.64Red blood cells 
(×106 cells/µL) G114 5.88 5.87 0.128 0.94
W26 5.56 5.83 0.115 0.10
Mean 5.72 5.85 0.089 0.29 0.15 0.24
Haemoglobin (g/dL) G100 14.55 13.61 1.081 0.56
G114 12.00 11.67 0.244 0.32
W26 11.27 11.37 0.219 0.73
Mean 11.64 11.52 0.175 0.61 0.03 0.32
Haematocrit (L/L) G100 0.47 0.44 0.032 0.51
G114 0.39 0.37 0.008 0.14
W26 0.36 0.37 0.007 0.67
Mean 0.38 0.37 0.005 0.40 0.05 0.16
G100 63.52 62.77 0.601 0.25Mean corpuscular 
volume (fL) G114 66.18 63.88 0.474 0.001
W26 65.01 63.23 0.431 <0.01
Mean 65.60 63.55 0.357 <0.001 0.03 0.51
G100 19.90 19.57 0.197 0.13Mean corpuscular 
haemoglobin 
(pg/cell) G114 20.47 19.93 0.154 0.01
W26 20.20 19.54 0.139 0.001
Mean 20.34 19.74 0.113 0.001 0.02 0.65
G100 31.33 31.14 0.220 0.56
G114 30.89 31.23 0.122 0.04




Mean 30.96 31.12 0.093 0.14 0.62 0.09
G100 120.80 161.51 27.197 0.31Platelets (×103 
cells/μL) G114 152.77 164.59 18.432 0.64
 W26 240.59 239.14 16.473 0.95
Mean 196.68 201.87 13.474 0.76 <0.001 0.68
1Least square means and pooled standard errors of the mean (SEM).
2CON: non-probiotic supplemented sows; 3PRO: probiotic-supplemented sows.
4Percentages are based on the differential count of white blood cells.
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Supplementary Table S3. Pre-weaning growth performance of piglets born to sows 
fed a control or a probiotic-supplemented diet1.
  Treatment  P-value








Off trial5 6 3 
Body weight (kg) Birth (D0) 1.48 1.47 0.029 0.90
D14 3.89 3.91 0.167 0.90
Weaning 
(D26)
7.24 7.30 0.168 0.69
Overall 0.150 0.71 <0.00
1
0.84


























1Least square means and pooled standard errors of the mean (SEM).
2CON: non-probiotic supplemented sows; 3PRO: probiotic-supplemented sows.
4Mortality: In CON group, mortality was due to overlay (N=12), starvation (N=11), and pot 
belly (N=1).  In PRO group, mortality was due to overlay (N=5) and starvation (N=8).
5Off trial: Runt piglets (CON, N=6 and PRO, N=3) that were removed from the trial.
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Supplementary Table S4. Effect of Bacillus altitudinis WIT588 spore supplementation to sow and piglet diets on small intestinal 
morphology of piglets at day 8 post-weaning1.
Maternal Control Control Probiotic Probiotic   P-value
Post-weaning (pw) Control Probiotic Control Probiotic Maternal 
CON/CON2 CON/PRO3 PRO/CON4 PRO/PRO5 SEM Maternal pw × pw
N 10 10 10 10
Duodenum
Goblet cells 14.2 13.5 14.3 15.5 1.62 0.52 0.88 0.54
Villous height (µm) 340.9 362.7 400.7 384.7 12.18 <0.01 0.81 0.13
Crypt depth(µm) 175.2 178.9 192.7 188.3 6.27 0.04 0.96 0.52
VH:CD ratio6 2.0 2.1 2.1 2.1 0.09 0.62 0.78 0.69
Villous area (µm2) 38819 42958 49822 48103 2565.7 <0.01 0.64 0.26
Crypt area (µm2) 6531 6946 7636 7335 380.9 0.06 0.88 0.35
Jejunum
Goblet cells 9.9 7.4 10.3 10.1 1.19 0.20 0.26 0.32
Villous height (µm) 346.5 346.1 345.7 379.9 11.41 0.16 0.15 0.14
Crypt depth(µm) 182.5 169.2 190.8 187.4 6.29 0.04 0.19 0.44
VH:CD ratio6 2.0 2.1 1.9 2.0 0.08 0.37 0.03 0.69
Villous area (µm2) 38151 39743 38426 45784 2773.5 0.26 0.12 0.31
Crypt area (µm2) 6918 6544 7615 8535 486.1 <0.01 0.58 0.19
Ileum
Goblet cells 11.8 15.6 15.9 15.9 1.79 0.22 0.30 0.30
Villous height (µm) 317.9 333.6 334.4 357.2 10.46 0.06 0.08 0.74
Crypt depth(µm) 180.2 186.0 182.1 191.8 5.62 0.50 0.18 0.73
VH:CD ratio6 1.8 1.9 1.9 1.9 0.07 0.41 0.48 0.85
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Villous area (µm2) 36571 38533 37001 46354 2438.5 0.10 0.03 0.14
Crypt area (µm2) 7116 7307 7006 8312 411.0 0.28 0.08 0.18
1Least square means and pooled standard errors of the mean (SEM).
2CON/CON, non-probiotic supplemented sow/non-probiotic supplemented piglet; 3CON/PRO, non-probiotic supplemented sow/probiotic-supplemented 
piglet; 4PRO/CON, probiotic-supplemented sow/non-probiotic supplemented piglet; 5PRO/PRO, probiotic-supplemented sow/probiotic-supplemented piglet.
6VH:CD ratio, villous height:crypt depth ratio.
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Figure 1. Intestinal morphology of duodenum sections taken on day 8 post-weaning from piglets born to 
sows receiving the B. altitudinis WT588-supplemented diet (A) or a control diet (B). The black line shows 
the villous height measurement. Boxplots show the significant effects of the maternal treatment on the crypt 
depth (C) and villous height (D) of the duodenum of the offspring. Significant differences between 
treatments are indicated as ** (P≤0.01) and * (0.01<P≤0.05). 
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The ARRIVE Essential 10
These items are the basic minimum to include in a manuscript. Without this information, readers and reviewers 
cannot assess the reliability of the findings.
Item Recommendation
Section/line 
number, or reason 
for not reporting
Study design 1 For each experiment, provide brief details of study design including:
a. The groups being compared, including control groups. If no control group has 
been used, the rationale should be stated.
b. The experimental unit (e.g. a single animal, litter, or cage of animals).
Sample size 2 a. Specify the exact number of experimental units allocated to each group, and the 
total number in each experiment. Also indicate the total number of animals used.
b. Explain how the sample size was decided. Provide details of any a priori sample 




3 a. Describe any criteria used for including and excluding animals (or experimental 
units) during the experiment, and data points during the analysis. Specify if these 
criteria were established a priori. If no criteria were set, state this explicitly.
b. For each experimental group, report any animals, experimental units or data points 
not included in the analysis and explain why. If there were no exclusions, state so.
c. For each analysis, report the exact value of n in each experimental group.
Randomisation 4 a. State whether randomisation was used to allocate experimental units to control 
and treatment groups. If done, provide the method used to generate the 
randomisation sequence. 
b. Describe the strategy used to minimise potential confounders such as the order 
of treatments and measurements, or animal/cage location. If confounders were 
not controlled, state this explicitly.
Blinding 5 Describe who was aware of the group allocation at the different stages of the 
experiment (during the allocation, the conduct of the experiment, the outcome 
assessment, and the data analysis).
Outcome 
measures
6 a. Clearly define all outcome measures assessed (e.g. cell death, molecular markers, 
or behavioural changes). 
b. For hypothesis-testing studies, specify the primary outcome measure, i.e. the 
outcome measure that was used to determine the sample size.
Statistical 
methods
7 a. Provide details of the statistical methods used for each analysis, including 
software used.
b. Describe any methods used to assess whether the data met the assumptions of 
the statistical approach, and what was done if the assumptions were not met.
Experimental 
animals
8 a. Provide species-appropriate details of the animals used, including species, strain 
and substrain, sex, age or developmental stage, and, if relevant, weight.
b. Provide further relevant information on the provenance of animals, health/immune 
status, genetic modification status, genotype, and any previous procedures.
Experimental 
procedures 
9 For each experimental group, including controls, describe the procedures in enough 
detail to allow others to replicate them, including: 
a. What was done, how it was done and what was used.
b. When and how often.
c. Where (including detail of any acclimatisation periods).
d. Why (provide rationale for procedures).
Results 10 For each experiment conducted, including independent replications, report:
a. Summary/descriptive statistics for each experimental group, with a measure of 
variability where applicable (e.g. mean and SD, or median and range).
b. If applicable, the effect size with a confidence interval.
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